|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,670 KRW | 0.00% |
|
+3.73% | -5.12% |
| 2023 | Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index | CI |
Optipharm.CO.,LTD reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 3.29 million compared to KRW 3.94 million a year ago. Net loss was KRW 915.63 million compared to KRW 914.85 million a year ago.
Basic loss per share from continuing operations was KRW 62 compared to KRW 63 a year ago. Basic loss per share was KRW 62 compared to KRW 63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.12% | 71.13M | |
| -19.04% | 72.97B | |
| -9.77% | 6.69B | |
| +21.38% | 3.6B | |
| +2.36% | 1.44B | |
| -16.99% | 1.34B | |
| -7.52% | 1.25B | |
| -26.05% | 1.24B | |
| -12.71% | 1.15B | |
| -4.03% | 1.01B |
OPTIPHARM.CO.,LTD 
